Global Health Ltd
NSE:MEDANTA
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
903.15
1 487.05
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Global Health Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | IN |
Market Cap | 299B INR |
Net Margin |
14%
|
Country | US |
Market Cap | 83.9B USD |
Net Margin |
9%
|
Country | SA |
Market Cap | 98B SAR |
Net Margin |
22%
|
Country | ZA |
Market Cap | 24.9B Zac |
Net Margin |
17%
|
Country | ZA |
Market Cap | 20.7B Zac |
Net Margin |
5%
|
Country | CN |
Market Cap | 133.2B CNY |
Net Margin |
18%
|
Country | MY |
Market Cap | 63.3B MYR |
Net Margin |
11%
|
Country | US |
Market Cap | 13.7B USD |
Net Margin |
15%
|
Country | US |
Market Cap | 13.1B USD |
Net Margin |
7%
|
Country | TH |
Market Cap | 421.1B THB |
Net Margin |
15%
|
Country | IN |
Market Cap | 997.2B INR |
Net Margin |
5%
|
Global Health Ltd
Glance View
Global Health Ltd. engages in the provision of healthcare, pathology, and other medical services. The company is headquartered in New Delhi, Delhi and currently employs 9,350 full-time employees. The company went IPO on 2022-11-16. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna and Lucknow through its network of five hospitals, six Mediclinic, diagnostic laboratories, homecare and telemedicine services. The company provides treatments for coronary artery disease, head and neck cancer, acute myeloid leukemia, epilepsy, hip fracture, Parkinson's disease, refractive error, prostate cancer, chronic kidney disease, cerebral stroke, sepsis, liver cirrhosis, rheumatoid, arthritis, hypertension, diabetes, bronchial asthma, stomach cancer, and chronic otitis media. Medanta specializes in cardiac surgery, nephrology, urology, andrology, dermatology, ophthalmology, radiology and imaging, dental sciences, and interventional cardiology, among others. Its facilities and services include medicine delivery, air ambulance, patient support services, and others.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Global Health Ltd's most recent financial statements, the company has Net Margin of 14.4%.